UCA1 and acute myeloid leukemia: Research reported that C/EBPα (CCAAT/enhancer-binding protein) and C/EBPα-p30 could negatively regulate lncRNA UCA1 expression by binding to the promoter and highly expressed AML cases with cytogenetically normal and carrying biallelic CEBPA mutation.